Clinical research and the mechanism of Cinobufotalin combination chemotherapy prevent the relapse and metastasis of colorectal cancer

ABSTRACT: Interventions: Trial group :Cinobufotalin combination chemotherapy ;Control:Chemotherapy Primary outcome(s): routine blood test;Urine routine test;Fecal routine test;Fecal occult blood;Liver and kidney function;Immune functionCD3?CD4;Tumor markers CA199, CEA, CA50, CA125;TCM Syndrome Rating Scale;Piper Fatigue Scale Study Design: Randomized parallel controlled trial

DISEASE(S): Colorectal Cancer

PROVIDER: 2666613 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR